NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 45,436 Value ($000) $72 Avg Close — Range —
Q4 2023
Shares 46,804 Value ($000) $40 Avg Close — Range —
Q3 2023
Shares 22,180 Value ($000) $24 Avg Close — Range —
Q1 2023
Shares 2,896 Value ($000) $12 Avg Close — Range —
Q4 2022
Shares 4,731 Value ($000) $24 Avg Close — Range —
Q4 2021
Shares 2,673 Value ($000) $47 Avg Close — Range —
Q3 2021
Shares 807 Value ($000) $17 Avg Close — Range —
Q2 2021
Shares 4,947 Value ($000) $98 Avg Close — Range —
Q1 2021
Shares 42,200 Value ($000) $1,226 Avg Close — Range —
Q4 2020
Shares 18,300 Value ($000) $554 Avg Close — Range —
Q3 2020
Shares 12,300 Value ($000) $196 Avg Close — Range —
Q2 2020
Shares 9,589 Value ($000) $189 Avg Close — Range —
Q1 2020
Shares 10,534 Value ($000) $130 Avg Close — Range —
Q4 2019
Shares 26,659 Value ($000) $492 Avg Close — Range —
Q3 2019
Shares 9,117 Value ($000) $127 Avg Close — Range —
Q2 2019
Shares 1,213 Value ($000) $18 Avg Close — Range —